The predictive value of patient-reported outcomes on the impact of breast cancer treatment-related quality of life

by Ke Zhou, Martine Bellanger, Martine Bellanger, Sophie Le Lann, Marie Robert, Jean-Sebastien Frenel, Jean-Sebastien Frenel, Jean-Sebastien Frenel, Mario Campone, Mario Campone, Mario Campone
Published 2022-10-01

Current options and future possibilities for the systemic treatment of hepatocellular carcinoma

by Jean-Luc Raoul, Jean-Sébastien Frenel, Judith Raimbourg, Marine Gilabert
Published 2019-03-01

Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer

by Pauline du Rusquec, Cyriac Blonz, Jean Sebastien Frenel, Mario Campone
Published 2020-07-01

The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients

by Mathilde Colombié, Pascal Jézéquel, Mathieu Rubeaux, Jean-Sébastien Frenel, Frédéric Bigot, Valérie Seegers, Mario Campone
Published 2021-03-01

Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper

by Jean-Luc Raoul, Julien Edeline, Victor Simmet, Camille Moreau-Bachelard, Marine Gilabert, Jean-Sébastien Frénel
Published 2022-02-01

Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes

by Amandine Billaud, Louise-Marie Chevalier, Paule Augereau, Jean-Sebastien Frenel, Christophe Passot, Mario Campone, Alain Morel
Published 2021-11-01

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis

by Elsa Curtit, Martine Marie Bellanger, Virginie Nerich, Delphine Hequet, Jean-Sebastien Frenel, Olivier Cristeau, Roman Rouzier
Published 2023-06-01

Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer

by Camille Domergue, Elodie Martin, Camille Lemarié, Pascal Jézéquel, Jean-Sebastien Frenel, Paule Augereau, Mario Campone, Anne Patsouris
Published 2022-05-01

miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker

by Arulraj Nadaradjane, Joséphine Briand, Gwenola Bougras-Cartron, Valentine Disdero, François M. Vallette, Jean-Sébastien Frenel, Pierre-François Cartron
Published 2018-12-01

Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner

by Manon Duforestel, Manon Duforestel, Manon Duforestel, Manon Duforestel, Arulraj Nadaradjane, Arulraj Nadaradjane, Arulraj Nadaradjane, Arulraj Nadaradjane, Gwenola Bougras-Cartron, Gwenola Bougras-Cartron, Gwenola Bougras-Cartron, Gwenola Bougras-Cartron, Joséphine Briand, Joséphine Briand, Joséphine Briand, Joséphine Briand, Christophe Olivier, Christophe Olivier, Christophe Olivier, Jean-Sébastien Frenel, Jean-Sébastien Frenel, Jean-Sébastien Frenel, Jean-Sébastien Frenel, François M. Vallette, François M. Vallette, François M. Vallette, François M. Vallette, Sophie A. Lelièvre, Sophie A. Lelièvre, Pierre-François Cartron, Pierre-François Cartron, Pierre-François Cartron, Pierre-François Cartron
Published 2019-09-01

Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients

by Camille Moreau-Bachelard, Loïc Campion, Marie Robert, Olivier Kerdraon, Céline Renaudeau, Maud Aumont, Jean-Marc Classe, Mario Campone, Jean-Sébastien Frénel
Published 2020-12-01

Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy

by Paule Augereau, Anne Patsouris, Emmanuelle Bourbouloux, Carole Gourmelon, Sophie Abadie Lacourtoisie, Dominique Berton Rigaud, Patrick Soulié, Jean Sebastien Frenel, Mario Campone
Published 2017-05-01

The von Willebrand factor stamps plasmatic extracellular vesicles from glioblastoma patients

by Quentin Sabbagh, Gwennan André-Grégoire, Carolina Alves-Nicolau, Aurélien Dupont, Nicolas Bidère, Emmanuel Jouglar, Laëtitia Guével, Jean-Sébastien Frénel, Julie Gavard
Published 2021-11-01

Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review

by Jean-Marc Classe, Bernard Asselain, Loic Campion, Dominique Berton, Jean-Sébastien Frenel, Fabrice Lécuru, Gwenael Ferron, Laurence Gladieff, Charlotte Bourgin, Cecile Loaec
Published 2021-12-01

NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.

by Nassima Redjimi, Karine Duperrier-Amouriaux, Isabelle Raimbaud, Immanuel Luescher, Danijel Dojcinovic, Jean-Marc Classe, Dominique Berton-Rigaud, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, Danila Valmori, Maha Ayyoub
Published 2011-01-01

Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells

by Nina Guyon, Delphine Garnier, Joséphine Briand, Arulraj Nadaradjane, Gwenola Bougras-Cartron, Judith Raimbourg, Mario Campone, Dominique Heymann, François M. Vallette, Jean-Sébastien Frenel, Pierre-François Cartron
Published 2020-12-01

Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.

by Ke Zhou, Marie Robert, Valérie Seegers, Audrey Blanc-Lapierre, Stéphane Savouroux, Frédéric Bigot, Jean-Sébastien Frenel, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Jean-Luc Raoul, Martine M Bellanger
Published 2024-01-01

Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma

by Loïg Vaugier, Loïc Ah-Thiane, Maud Aumont, Emmanuel Jouglar, Mario Campone, Camille Colliard, Ludovic Doucet, Jean-Sébastien Frenel, Carole Gourmelon, Marie Robert, Stéphane-André Martin, Tanguy Riem, Vincent Roualdes, Loïc Campion, Augustin Mervoyer
Published 2021-11-01

Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program

by Alexandre de Moura, Perrine Vuagnat, Benjamin Renouf, Jean-Yves Pierga, Delphine Loirat, Pauline Vaflard, Charline Lafayolle de la Bruyère, Natacha Chaumard-Billotey, Nawale Hajjaji, Sylvain Ladoire, Sandrine Dabakuyo, Anne Patsouris, Jean Sébastien Frenel, Vincent Nicolai, Marie Alexandre, Nadine Dohollou, Julien Grenier, Heloïse Bourien, François-Clément Bidard
Published 2023-08-01

Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VI...

by Nour‐El‐Houda Mourksi, Cécile Dalban, Amélie Colombe‐Vermorel, Laetitia Odeyer, Valentin Simioni, Jean‐Sébastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie‐Lacourtoisie, Elodie Coquan, Séverine Martinez, Gwenaelle Garin, Séverine Tabone‐Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Pérol, Isabelle Ray‐Coquard, Pierre‐Etienne Heudel, Jean‐Jacques Diaz, Virginie Marcel
Published 2023-01-01